Business Description
Jia Jie Biomedical Co Ltd
ISIN : TW0004109004
Compare
Compare
Traded in other countries / regions
4109.Taiwan IPO Date
2002-08-08Description
Jia Jie Biomedical Co Ltd is a Taiwan-based company. It is engaged in the turtle shellfish, turtle eggs, turtle oil and other turtle food processing manufacturing sales trading business. It has two reportable segments: Taiwan Operating Segment and Mainland China Operating Segment. The Taiwan Operating Segment is mainly engaged in production and distribution segment of nutritional health products and insurance brokerage, while the Mainland China Operating Segment is mainly engaged in the sale of water purification equipment and related parts.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 48.45 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 14.58 | |||||
| Beneish M-Score | 0.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.4 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.02 | |||||
| 9-Day RSI | 24.92 | |||||
| 14-Day RSI | 29.69 | |||||
| 3-1 Month Momentum % | -8.87 | |||||
| 6-1 Month Momentum % | 18.43 | |||||
| 12-1 Month Momentum % | 65.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.22 | |||||
| Quick Ratio | 2.93 | |||||
| Cash Ratio | 2.47 | |||||
| Days Inventory | 25.77 | |||||
| Days Sales Outstanding | 20.31 | |||||
| Days Payable | 15.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.25 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| Forward Dividend Yield % | 2.25 | |||||
| 5-Year Yield-on-Cost % | 2.2 | |||||
| Shareholder Yield % | -4.53 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.72 | |||||
| Operating Margin % | -0.68 | |||||
| Net Margin % | 79.77 | |||||
| FCF Margin % | 2.18 | |||||
| ROE % | 33.73 | |||||
| ROA % | 28.57 | |||||
| ROIC % | -0.32 | |||||
| 3-Year ROIIC % | -6.52 | |||||
| ROC (Joel Greenblatt) % | 88.38 | |||||
| ROCE % | 33.59 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.46 | |||||
| PE Ratio without NRI | 5.46 | |||||
| Price-to-Owner-Earnings | 6.06 | |||||
| PS Ratio | 4.47 | |||||
| PB Ratio | 1.65 | |||||
| Price-to-Tangible-Book | 1.71 | |||||
| Price-to-Free-Cash-Flow | 211.8 | |||||
| Price-to-Operating-Cash-Flow | 148.11 | |||||
| EV-to-EBIT | 4.83 | |||||
| EV-to-EBITDA | 4.65 | |||||
| EV-to-Revenue | 3.95 | |||||
| EV-to-FCF | 204.29 | |||||
| Price-to-GF-Value | 0.96 | |||||
| Price-to-Projected-FCF | 1.98 | |||||
| Price-to-Median-PS-Value | 1.26 | |||||
| Price-to-Graham-Number | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 10.8 | |||||
| Price-to-Net-Cash | 17.8 | |||||
| Earnings Yield (Greenblatt) % | 20.68 | |||||
| FCF Yield % | 0.48 | |||||
| Forward Rate of Return (Yacktman) % | -2.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jia Jie Biomedical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 491.167 | ||
| EPS (TTM) (NT$) | 4.15 | ||
| Beta | 0.22 | ||
| 3-Year Sharpe Ratio | 0.63 | ||
| 3-Year Sortino Ratio | 1.2 | ||
| Volatility % | 44.44 | ||
| 14-Day RSI | 29.69 | ||
| 14-Day ATR (NT$) | 0.717939 | ||
| 20-Day SMA (NT$) | 24.0275 | ||
| 12-1 Month Momentum % | 65.81 | ||
| 52-Week Range (NT$) | 16 - 39.6 | ||
| Shares Outstanding (Mil) | 98.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jia Jie Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jia Jie Biomedical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jia Jie Biomedical Co Ltd Frequently Asked Questions
What is Jia Jie Biomedical Co Ltd(ROCO:4109)'s stock price today?
The current price of ROCO:4109 is NT$22.25. The 52 week high of ROCO:4109 is NT$39.60 and 52 week low is NT$16.00.
When is next earnings date of Jia Jie Biomedical Co Ltd(ROCO:4109)?
The next earnings date of Jia Jie Biomedical Co Ltd(ROCO:4109) is .
Does Jia Jie Biomedical Co Ltd(ROCO:4109) pay dividends? If so, how much?
The Dividend Yield %  of Jia Jie Biomedical Co Ltd(ROCO:4109) is 2.25% (As of Today), Highest Dividend Payout Ratio of Jia Jie Biomedical Co Ltd(ROCO:4109) was 1.31. The lowest was 0.12. And the median was 0.96. The  Forward Dividend Yield % of Jia Jie Biomedical Co Ltd(ROCO:4109) is 2.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers